TB-500 (0.5mg/capsule), 60 Capsules

TB-500 (Thymosin Beta-4) capsules provide an oral administration format for the 43-amino-acid actin-binding peptide, enabling oral route investigations alongside the lyophilized vial format. As with the injectable format, the active compound interacts with G-actin through its LKKTET motif, influencing actin polymerization dynamics, cytoskeletal organization, and cell migration–associated signaling pathways. Experimental investigations have examined TB-500 in relation to actin-regulatory mechanisms, molecular signaling networks, and pathway-specific processes involved in cytoskeletal biology. Research applications include oral versus parenteral comparative studies, actin cytoskeletal pathway investigation, cell migration signaling research, and mechanistic evaluation of actin-associated regulatory systems.